Higher serotonin-1A (5-HT 1A ) receptor binding potential (BP F ) has been found in major depressive disorder (MDD) during and between major depressive episodes. We investigated whether higher 5-HT 1A binding is a biologic trait transmitted to healthy high risk (HR) offspring of MDD probands. Data were collected contemporaneously from: nine HR, 30 depressed not-recently medicated (NRM) MDD, 18 remitted NRM MDD, 51 healthy volunteer (HV) subjects. Subjects underwent positron emission tomography (PET) using [
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A B S T R A C T
Higher serotonin-1A (5-HT 1A ) receptor binding potential (BP F ) has been found in major depressive disorder (MDD) during and between major depressive episodes. We investigated whether higher 5-HT 1A binding is a biologic trait transmitted to healthy high risk (HR) offspring of MDD probands. Data were collected contemporaneously from: nine HR, 30 depressed not-recently medicated (NRM) MDD, 18 remitted NRM MDD, 51 healthy volunteer (HV) subjects. Subjects underwent positron emission tomography (PET) using [
11 C]
WAY100635 to quantify 5-HT 1A BP F , estimated using metabolite, free fraction-corrected arterial input function and cerebellar white matter as reference region. Multivoxel pattern analyses (MVPA) of PET data evaluated group status classification of individuals. When tested across 13 regions of interest, an effect of diagnosis is found on BP F which remains significant after correction for sex, age, injected mass and dose: HR have higher BP F than HV (84.3% higher in midbrain raphe, 40.8% higher in hippocampus, mean BP F across all 13 brain regions is 49.9% ± 11.8% higher). Voxel-level BP F maps distinguish HR vs. HV. Elevated 5-HT 1A BP F appears to be a familially transmitted trait abnormality. Future studies are needed to replicate this finding in a larger cohort and demonstrate the link to the familial transmission of mood disorders.
Introduction
Depressive disorders are estimated to be 40% heritable (Uhl and Grow, 2004) , and offspring of individuals with early-onset depression are at higher risk of developing these disorders (Mann et al., 2005) . The serotonin (5-HT) system has been implicated in major depressive disorder (MDD) (Blier et al., 1990) , and offspring of MDD patients report transient depression after serotonin depletion by acute tryptophan depletion (Klaassen et al., 1999) . An endophenotype of MDD may help to identify persons at elevated risk of developing MDD (HR or high risk) while still healthy (no history of a mood disorder). A biomarker or endophenotype could also: (a) improve diagnostic classification by identification of biologic subtypes; (b) improve treatment outcome if biologic subtypes respond to different treatments; (c) guide the search for genetic and environmental factors that mediate the vulnerability to mood disorders and are modifiable to inform a prevention strategy; and (d) help develop and validate animal models of depression.
We have previously reported elevated serotonin-1A (5-HT 1A ) receptor binding in MDD during a major depressive episode (MDE) across 13 brain regions known to have high 5-HT 1A receptor density (Parsey et al., 2010a (Parsey et al., , 2006 . Most studies (Bhagwagar et al., 2004; Drevets et al., 1999Drevets et al., 2007 Sargent et al., 2000; Shively et al., 2006) have not replicated our findings, but we have demonstrated that a key contributor to divergent findings is the choice of outcome measure of binding potential (BP F , BP ND , or BP P , as defined using published consensus nomenclature (Innis et al., 2007) ) and reference region (RR) (Parsey et al., 2010a) . Two studies in depressed humans (N = 16 (Drevets et al., 2007) , N = 25 (Sargent et al., 2000) ) and one study in
